KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Debt to Equity (2016 - 2026)

Quest Diagnostics' Debt to Equity history spans 18 years, with the latest figure at $0.74 for Q1 2026.

  • On a quarterly basis, Debt to Equity fell 12.3% to $0.74 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.74, a 12.3% decrease, with the full-year FY2025 number at $0.79, down 13.32% from a year prior.
  • Debt to Equity hit $0.74 in Q1 2026 for Quest Diagnostics, down from $0.79 in the prior quarter.
  • Over the last five years, Debt to Equity for DGX hit a ceiling of $0.91 in Q3 2024 and a floor of $0.62 in Q2 2022.
  • Historically, Debt to Equity has averaged $0.73 across 5 years, with a median of $0.73 in 2024.
  • Biggest five-year swings in Debt to Equity: surged 38.96% in 2024 and later decreased 14.43% in 2025.
  • Tracing DGX's Debt to Equity over 5 years: stood at $0.67 in 2022, then increased by 10.72% to $0.74 in 2023, then grew by 22.79% to $0.91 in 2024, then fell by 13.32% to $0.79 in 2025, then fell by 6.68% to $0.74 in 2026.
  • Business Quant data shows Debt to Equity for DGX at $0.74 in Q1 2026, $0.79 in Q4 2025, and $0.78 in Q3 2025.